Scilex Pharmaceuticals

Patent cliffs & loss of exclusivity

Scilex Pharmaceuticals is a company focused on the development and commercialization of non-opioid pain management products.

Company

Also Known AsScilex Pharmaceuticals Inc.
AngelList URLhttps://angel.co/scilex-pharmaceuticals
Crunchbase URLhttps://www.crunchbase.com/organization/scilex-pharmaceuticals
LinkedIn URLhttp://www.linkedin.com/company/scilex-pharmaceuticals-inc-
Official Websitehttp://scilexpharma.com
Wellfound IDscilex-pharmaceuticals

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. ZTLIDOLIDOCAINESmall mol.May 2031
  2. ELYXYBCELECOXIBSmall mol.May 2036
  3. GLOPERBACOLCHICINESmall mol.Dec 2037

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Scilex Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio